Novartis Investigative Site

Lancaster, California 93534

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Chronic Spontaneous Urticaria, Hepatitis C, Liver Disease

Studies at this site

• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option — Completed